Post-transplantation lymphoproliferative disorder in pediatric patient.
Immunosuppressive therapy for transplanted patients exposes them to a high risk of developing posttransplantation lymphoproliferative disorders (PTLD). We report the case of a child undergoing heart transplantation at seven months of age who developed PTLD at nine years of age, diagnosed by resection of a pulmonary nodule.
Fernandes
Paulo Manuel Pêgo
PM
Instituto do Coração, Hospital das Clínicas, FM, USP, São Paulo, SP, Brazil. paulopego@cardiol.br
Azeka
Estela
E
Odoni
Vicente
V
Junqueira
Jader Joel Machado
JJ
Bento
Gabriella Paiva
GP
Aiello
Vera
V
Barbero-Marcial
Miguel
M
D002311:Cardiomyopathy, Dilated / Q000601:surgery; D002648:Child; D016027:Heart Transplantation / Q000009:adverse effects*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D008232:Lymphoproliferative Disorders / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology*; D008297:Male; D016896:Treatment Outcome
D007166:Immunosuppressive Agents